+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Differences in megakaryocyte progenitor ex vivo expansion between CD34+ cells derived from human umbilical cord blood and bone marrow



Differences in megakaryocyte progenitor ex vivo expansion between CD34+ cells derived from human umbilical cord blood and bone marrow



Zhongguo Shi Yan Xue Ye Xue Za Zhi 16(6): 1398-1402



The purpose of this study was to explore the differences in megakaryocyte progenitor ex vivo expansion between CD34+ cells derived from human umbilical cord blood (CB) and bone marrow (BM). Mononuclear cells (MNCs) were obtained from CB or BM by Ficoll-Hypaque density gradient separation. CD34+ cells were purified by magnetic cell sorting (MACS). The selected CD34+ cells were seeded in serum-free conditions stimulated with thrombopoietin (TPO), TPO+interleukin 11 (IL-11), or TPO+IL11+heparin for 14 days. Amplification product (CD34+, CD41a+, and CD34+ CD41a+ cells) immunophenotypes, megakaryocyte apoptosis rates and the DNA content were measured by fluorescence-activated cell sorting (FACS). The colony-forming units of granulocytes and monocytes (CFU-GM), burst-forming units of erythrocytes (BFU-E), and colony-forming units of megakaryocytes (CFU-Mk) were also evaluated by the colony-forming units (CFU) assay. The results indicated that CD34+ cells derived from CB showed higher expansion ability of total cell counts, CD41a+ and CD34+ CD41a+ cells than those derived from BM for all days 14 of culture (p<0.05, respectively). There were no significant differences in CFU-GM, BFU-E, and total CFU-Mk counts between CB and BM-derived CD34+ cells on day 0 (p>0.05, respectively), but CB-derived CFU-Mk seemed mainly large colonies, and the number of large colonies was higher than that from BM (p<0.05) on day 0. There were no significant differences in expansion ability of CFU-GM between CB and BM-derived cells on days 7, 10, and 14 of culture (p > 0.05, respectively), but the expansion ability of BFU-E and CFU-Mk derived from CB cells was higher than that from BM (p<0.05, respectively). There were no significant differences in apoptosis rates of megakaryocyte from two source cells for days 14 of culture. Megakaryocytes derived from CB mostly showed the 2N DNA content (>90%) for days 14 of culture, while those cells derived from BM showed the increased DNA content, and 4N, 8N or more ploidy cells gradually increased with prolonging of culture time. It is concluded that CB-derived CD34+ cells have a greater proliferation potential than that derived from BM, which is therefore proven to be a better cell source for megakaryocyte progenitor expansion in vitro.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 052602382

Download citation: RISBibTeXText

PMID: 19099652


Related references

A study of ex vivo expansion by cytokines of umbilical cord blood and bone marrow derived CD34+ progenitor cells. Blood 82(10 Suppl. 1): 484A, 1993

Ex vivo expansion of CD34+ cells from purified adult human bone marrow and umbilical cord blood hematopoietic progenitor cells. Progress in Clinical and Biological Research 389: 385-391, 1994

Differences in megakaryocyte expansion potential between CD34+ stem cells derived from cord blood, peripheral blood, and bone marrow from adults and children. Experimental Hematology 28(9): 1054-1061, 2000

Ex vivo expansion of megakaryocyte progenitor cells for CD133(+) cells derived from human umbilical cord blood. Zhongguo Shi Yan Xue Ye Xue Za Zhi 16(3): 645-649, 2008

Comparison of ex vivo expansion of megakaryocytic cells from CD34-selected bone marrow, umbilical cord blood and mobilized peripheral blood progenitor cells. Blood 94(10 Suppl. 1 Part 2): 347b, 1999

Ex-vivo expansion of human bone marrow and cord blood CD34+ progenitor cells. Blood 82(10 Suppl. 1): 17A, 1993

Ex vivo expansion of megakaryocyte progenitors from human umbilical cord blood CD34(+) cells. Zhongguo Shi Yan Xue Ye Xue Za Zhi 16(5): 1121-1125, 2008

Ex vivo expansion of CD34+ cells from human umbilical cord blood by FL gene transfected bone marrow stromal cells. Zhongguo Shi Yan Xue Ye Xue Za Zhi 11(4): 341-344, 2003

Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood. Experimental Hematology 25(11): 1125-1139, 1997

Comparison of retroviral-mediated gene transfer into cultured human CD34+ hematopoietic progenitor cells derived from peripheral blood, bone marrow, and fetal umbilical cord blood. Biology of Blood and Marrow Transplantation 3(5): 273-281, 1997

Ex-vivo expansion of human marrow and cord blood CD34+ progenitor cells. Journal of Cellular Biochemistry Suppl. 0(18 Part A): 11, 1994

Expansion of human umbilical cord blood-derived CD34+ Stem/Progenitor cells to treat myocardial infarction. Blood 102(11): 693a, 2003

Ex vivo expansion and phenotypic analysis of CD34+ cells from mobilized peripheral blood, bone marrow and umbilical cord blood. Blood 90(10 Suppl. 1 Part 2): 342B, 1997

Effect of a bone marrow microenvironment on the ex-vivo expansion of umbilical cord blood progenitor cells. International Journal of Laboratory Hematology 29(1): 58-63, 2007

Different cytokine requirements for optimal ex vivo expansion of CD34+ hematopoietic cells from umbilical cord blood and bone marrow. Blood 94(10 Suppl. 1 Part 2): 349b, 1999